Shengshi Baicao focuses on the standardized planting of high-quality Chinese medicinal materials and the production and operation of Chinese herbal medicines. Member companies include Shengshibaicao Pharmaceutical Co., Ltd., Jilin Lincun Traditional Chinese Medicine Development Co., Ltd., Baishan Lincun Traditional Chinese Medicine Development Co., Ltd. and Beijing Shengshi Traditional Chinese Medicine Clinic Co., Ltd., among which Shengshibaicao Pharmaceutical Co., Ltd. is the core business platform.

Shengshi Baicao takes "let the Chinese people use real good Chinese medicine" as its core mission, and based on the advantages of the entire industrial chain, it provides domestic and foreign customers with accurate efficacy, controllable quality, safe and reliable Chinese medicine products and the best solutions.

The company operates more than 100 authentic Chinese medicinal products such as ginseng, licorice, Pinellia ternata, asarum, and ephedra, as well as commonly used clinically refined Chinese herbal medicine products.

Relying on its international business resources advantages, the company has made a full industrial chain resource layout in the fields of traditional Chinese medicinal materials and Chinese herbal medicines. It was the first in China to establish and practice GACP standards, and has built more than 180,000 mu of standardized Chinese medicinal materials planting bases in many medicinal materials production areas across the country. It has built an internationally first-class and domestically leading Chinese medicinal materials and Chinese medicinal decoction processing center in Tianjin. Its design Both the operation complies with the international PIC/S GMP specifications and has passed the certification of overseas factories in Japan; the company's testing center has successfully passed the CNAS certification, which can meet the inspection technical requirements of international markets such as Europe, America, Japan and South Korea, and is committed to creating a high-level industry Traceable management system for the entire process of Chinese medicinal materials and Chinese herbal medicines.

The company is driven by technological innovation, and is with the Chinese Academy of Traditional Chinese Medicine, the Fifth Medical Center of the General Hospital of the People's Liberation Army (formerly the Institute of Traditional Chinese Medicine of the 302 Hospital), the Institute of Medicinal Plants of the Chinese Academy of Medical Sciences, Tianjin University of Traditional Chinese Medicine, Japan's Tsumura Institute of Pharmacy and other authoritative Chinese medicine research institutions have carried out a number of scientific research cooperation projects. On this basis, the company undertakes a number of major national and provincial projects, including national traditional Chinese medicine standardization projects and traditional Chinese medicine production support projects, providing strong technical support for the company's career development. Among them, the "Chinese Herbal DNA Barcode Species Identification System" project jointly carried out by the company and the Chinese Academy of Traditional Chinese Medicine and other institutions won the second prize of the 2016 National Science and Technology Progress Award. The company has jointly undertaken a national project with the Fifth Medical Center of the General Hospital of the People's Liberation Army of China and has been approved for a number of national invention patents.

The company was rated as "2017 Industrial Brand Cultivation Demonstration Enterprise" by the Ministry of Industry and Information Technology, and won the title of "Tianjin High-tech Zone Advanced Technology Innovation Enterprise of 2018", and was rated as "Industry Leading Enterprise" and "Tianjin's 'Specialized and New' Small and Medium-sized Enterprises". ", "Tianjin Labor Relations Harmonious Enterprise", the technology center was recognized by Tianjin as "Tianjin Enterprise Technology Center". In 2022, it won the "Tianjin May 1st Labor Certificate" and was rated as a Class A-level Pharmaceutical Production Enterprise in Tianjin for many years and the title of "Tianjin Fangxin Pharmaceutical Factory".